-
Recent Posts
Recent Comments
- MichaelOrdman on Enriched seaweed can feed the world
- Professor Rajan Rajan on Enriched seaweed can feed the world
- MichaelOrdman on Fast glaucoma treatment in trials
- Lili Eylon on Fast glaucoma treatment in trials
- Investment in Israeli startups (25/10/20) - Israel Active on Syte is so cool
Archives
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- July 2010
Categories
Meta
Search Results for: immun cancer
Immunotherapy to fight cancer
Israeli biotech Efranat Ltd. is developing an immunotherapy treatment approach for cancer, based on a glycoprotein named GcMAF (Globulin component Macrophage Activating Factor). Efranat has just raised $4.5 million and is conducting trials at Tel Hashomer’s Sheba Medical Center. http://jewishbusinessnews.com/2014/11/21/israels-efranat-raises-4-5-million-to-acure-cancer/
Posted in Israel's Medical Achievements
Leave a comment
Drug boosts immune system to fight cancer
I reported in May that Israeli biotech Compugen discovered 4 new protein variants that stimulate the immune system into targeting cancer cells. Now tests have shown that CGEN-15001T will fight carcinomas, sarcomas, melanoma and haematological cancers. http://www.globes.co.il/serveen/globes/docview.asp?did=1000721404&fid=1725
Posted in Israel's Medical Achievements
Leave a comment
Predicting response to cancer therapy
Immune Checkpoint Inhibitors (ICIs) are successful in 40% of cancer patients but are invasive and time-consuming. Scientists at Israel’s Technion Institute have developed a tool that predicts the response based on the metabolic activity in the immune system cells. (See … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
Nitric Oxide for cancer
Israel’s Beyond Air (see here previously) has partnered with US-based Beyond Cancer to produce a form of immunotherapy for solid tumors known as ultra-high concentration nitric oxide (UNO). The ultra-high concentration of UNO is undergoing Phase 1 human trials. https://nocamels.com/category/news-briefs/#post-126279
Posted in Israel's Medical Achievements
Leave a comment
Light-activated cancer treatment gets US support
Israel’s ImPact Biotech has received Orphan treatment designation from the US FDA for its Padeliporfin VTP in Pancreatic Cancer. ImPact stands for IMmune Photo Activated Cancer Treatment and VTP is Vascular Targeted Photodynamic therapy. https://impactbiotech.com/impact-biotech-receives-fda-orphan-drug-designation-for-padeliporfin-vtp-in-pancreatic-cancer/ https://impactbiotech.com/
Posted in Israel's Medical Achievements
Leave a comment
007 – license to kill cancer cells
Israel’s Edity Therapeutics reprograms immune cells to recognize tumors that hide from the body’s regular immune system. Edity’s ED 007 cell therapy inflames these tumors, triggering the body’s own immune system to kill the cancer without risk of side effects … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
US award for cancer research
The US National Foundation for Cancer Research (NFCR) honored Tel Aviv University Professor Isaac P. Witz, for his cancer research on how components of the immune system infiltrate the tumor microenvironment (TME) affecting tumor formation, progression, and metastasis. https://en-lifesci.tau.ac.il/news/2023/witz/prize https://www.jpost.com/israel-news/article-747716
Posted in Israel is Inclusive & Global
Leave a comment
Predicting immunotherapy response
Ben-Gurion University researchers have partnered Israel’s OncoHost to develop a biosensor that safely predicts if anti-PD1 therapy may cure a specific cancer patient. The leading immune checkpoint inhibitor (ICI) therapy is invasive and other treatments may be better. (see also … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
Weighty cancer discovery
Researchers at Israel’s Weizmann Institute have analyzed the build-up of ammonia that impairs immune cells in 50% of cancer patients. It blocks the protein regulator HNF4-alpha, causing weight loss and tumor growth. In lab tests, restoring HNF4-alpha production stops weight … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
How the gut impacts cancer treatment
A Weizmann Institute-led international team of researchers has found how bacteria in the gut microbiome affects the body’s response to cancer immunotherapy (see also here previously). Also, patients treated with specific antibiotics had a poor response to CAR-T cancer treatment. … Continue reading
Posted in Israel's Medical Achievements
Leave a comment